WCM
HBIO icon

Weber Capital Management’s Harvard Bioscience HBIO Stock Holding History

Weber Capital Management’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
310,861
-9,176
-3% -$55K 1.63% 11
2026
Q1 		$1.56M Sell
320,037
-1
-0% -$6 1.56% 12
2025
Q4 		$2.14M Buy
+320,038
New +$1.9M 2.02% 12

Other funds holding HBIO

MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Weber Capital Management's HBIO Position: Q2 2026 in Review

Weber Capital Management reduced its Harvard Bioscience (HBIO) stake by 2.9% in Q2 2026, selling an estimated $55K and leaving 310,861 shares worth $1.91M. The position accounts for 1.63% of the portfolio, ranked #11.

Weber Capital Management first reported a position in HBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.14M in Q4 2025. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

  • Weber Capital Management held 310,861 shares of Harvard Bioscience worth $1.91M as of Q2 2026.
  • Weber Capital Management sold 9,176 Harvard Bioscience shares in Q2 2026, an estimated $55K.
  • Harvard Bioscience made up 1.63% of Weber Capital Management's portfolio in Q2 2026, its #11 holding.
  • Weber Capital Management first reported a position in Harvard Bioscience in Q4 2025 and has held it in 3 quarters since.
  • Weber Capital Management's Harvard Bioscience position peaked at $2.14M in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on Weber Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.